Durect corporation reports first quarter 2024 financial results and business update

-         fda feedback supports single pivotal trial for approval of larsucosterol in alcohol-associated hepatitis -         webcast of earnings call today, may 13th at 4:30 p.m. et cupertino, calif.
DRRX Ratings Summary
DRRX Quant Ranking